Neuropathic pain drugs
also: amitriptyline · duloxetine · gabapentin · pregabalin · trigeminal neuralgia
Overview
First-line neuropathic-pain agents (choose one, switch if it fails) and the special cases — trigeminal neuralgia and diabetic neuropathy.
Mechanism
Amitriptyline (TCA) and duloxetine (SNRI) augment descending noradrenergic/serotonergic inhibition. Gabapentin/pregabalin bind the α2δ subunit of voltage-gated Ca²⁺ channels → ↓excitatory neurotransmitter release. Carbamazepine stabilises Na⁺ channels (trigeminal neuralgia).
Indications
- Neuropathic pain (diabetic, post-herpetic, etc.)
- Trigeminal neuralgia (carbamazepine)
- Fibromyalgia (duloxetine/amitriptyline)
The agents
NICE: try one first-line; if it fails, switch to another. Duloxetine first-line specifically for diabetic neuropathy.
First-line for trigeminal neuralgia.
topical
Localised neuropathic pain.
Adverse effects
Now controlled drugs (Class C) — misuse potential.
Cautions & contraindications
Interactions
- Gabapentinoid + opioid (respiratory depression)
- Duloxetine + other serotonergics
Monitoring & kinetics
Pain response (review/switch if inadequate); mood
Oral, titrated. Standard analgesics (the WHO ladder) work poorly in neuropathic pain.
Source: NICE CG173 — Neuropathic pain · BNF — Neuropathic pain